HY-13653

99.75%, Anticancer Agent

Endogenous Metabolite; Apoptosis

Inflammation/Immunology; Cancer

HY-P0201

99.60%, Neurotransmitter

Neurokinin Receptor; Endogenous Metabolite

Neurological Disease; Metabolic Disease; Infection; Cancer

HY-115768

99.98%, Mast Cell Activator

Phospholipase

Neurological Disease; Cancer

HY-N0011

99.94%, CXCR4 Inhibitor

CXCR; Apoptosis

Inflammation/Immunology; Endocrinology; Cancer

HY-N0057

98.15%, Antioxidant

Glycosidase; Influenza Virus; Apoptosis; Endogenous Metabolite

Infection; Cancer

HY-13930

99.96%, CBR1 Inhibitor

Endogenous Metabolite

Neurological Disease; Cancer

HY-N0652

99.91%, Natural Product

ERK; NF-κB

Neurological Disease; Cardiovascular Disease

HY-P3419

99.40%, MrgX2 Agonist

Mas-related G-protein-coupled Receptor (MRGPR); PERK; Calcium Channel

Inflammation/Immunology; Cardiovascular Disease

HY-N0502

99.76%, Antioxidant Compound

Reactive Oxygen Species (ROS)

Metabolic Disease; Cancer

HY-118069

99.83%, MRGPRX2 Agonist

Mas-related G-protein-coupled Receptor (MRGPR)

Infection

HY-N1548

99.56%, DNA Polymerase β Inhibitor

DNA/RNA Synthesis

Inflammation/Immunology

HY-N2481

99.83%, Metabolite Of Oroxylin A

Prolyl Endopeptidase (PREP); Drug Metabolite; JNK; PPAR; NF-κB; Interleukin Related

Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease; Cancer

HY-N0631

99.99%, MAPK/NF-κB Inhibitor

p38 MAPK; NF-κB; JNK; Cholinesterase (ChE); Acyltransferase; NO Synthase; Interleukin Related; TNF Receptor; Prostaglandin Receptor; ERK; COX

Neurological Disease; Inflammation/Immunology

HY-172458

98.72%, MrgX2 Antagonist

Mas-related G-protein-coupled Receptor (MRGPR); TNF Receptor

Inflammation/Immunology

HY-N8165

99.67%, Flavonoid Glycoside

Others

Others